Effects of Ginkgo Extract on the Activity of CYP4A4 During Hepatocarcinogenesis Induced by AFB1 in Wistar Rats

ZHENG Hai-ping,OU Chao,CAO Ji,LI Yuan,SU Jian-jia,LI Guo-jian
DOI: https://doi.org/10.3969/j.issn.1008-0805.2012.07.027
2012-01-01
Abstract:Objective To investigate the effects of Ginkgo giloba extract(extract 761 from Ginkgo giloba,EGb761)on the activity of CYP3A4 during hepatocarcinogenesis induced by aflatoxin B1(AFB1) in wistar rats. Methods Seventy Wistar rats were randomly divided into 3 groups: AFB1 group(25),AFB1+EGb761 group(25) and control group(20).During hepatocarcinogenesis,liver biopsies were performed on all animals in 13th-,23rd-,33rd-,43rd-,53rd-and 63rd-week of the experiment.Animals were sacrificed in the 73rd-week and liver tissues were collected.Using the hepatic microsomal mixed-function oxidase enzyme system,the activity of CYP3A4 was dynamically examined in liver samples by quantitative fluorescence spectrophotometry. Results The incidence of hepatocellular carcinoma(HCC) in AFB1+EGb761 group was significantly lower than that in AFB1 group(P0.01).No hepatocellular carcinoma developed in control group.In the whole experiment process,the CYP3A4 metabolic enzymes activity shows double peaks in each groups with dynamic observation.The activity of CYP3A4 in AFB1+EGb761 group was significantly lower than that in AFB1 group in 53rd-and 63rd-week(P0.05). Conclusion The Ginkgo biloba extract(EGb761) can effectively inhibit the occurrence of hepatocellular carcinoma induced by AFB1.The activity of CYP3A4 can be inhibited during hepatocarcinogenesis in AFB1+EGb761 groups.The mechanism of treatment may be due to the decrease of carcinogens metabolic and that reduce carcinogenicity and hepatic injury of chemical to attain the role of protect liver.
What problem does this paper attempt to address?